Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Absorptiometry, Photon × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 3 Lymphoma, Non-Hodgkin 2 Wilms Tumor 1 Smoldering Multiple Myeloma 1 Sarcoma, Ewing 1 Ovarian Neoplasms 1 Osteosarcoma 1 Osteoporosis 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hodgkin Disease 1 Hepatoblastoma 1 Hematopoietic and Lymphoid System Neoplasm 1 Endometrial Neoplasms 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Clinical Stage III Cutaneous Melanoma AJCC v8 1 Carcinoma, Hepatocellular 1 Breast Carcinoma In Situ 1

Interventions

pembrolizumab 38 Gemcitabine 20 enfortumab vedotin 19 Cisplatin 17 Nivolumab 16 atezolizumab 14 Magnetic Resonance Spectroscopy 14 avelumab 13 Carboplatin 12 Specimen Handling 10 Docetaxel 10 sacituzumab govitecan 9 Paclitaxel 7 Ipilimumab 7 Fluorodeoxyglucose F18 5 pemigatinib 4 toripalimab 3 erdafitinib 3 durvalumab 3 cabozantinib 3 X-Rays 3 Taxes 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 tislelizumab 2 lenvatinib 2 eribulin 2 dodecyl maltoside 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡